Do analysts prefer SONX or ZJYL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, SONX or ZJYL?

Jin Medical International has lower revenue, but higher earnings than Sonendo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sonendo $44.40M 0.11 -$60.92M -$71.12 N/A Jin Medical International $20.69M 0.65 $1.19M N/A N/A

Do analysts prefer OSRH or SONX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings & valuation, OSRH or SONX?

OSR has higher earnings, but lower revenue than Sonendo. OSR is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OSR $2.63M 5.65 -$27.06M -$0.33 N/A Sonendo $44.40M 0.11 -$60.92M -$71.12 N/A

Is OSRH or SONX more profitable?

Sonendo has a net margin of -92.74% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets OSR -363.26% -7.24% -5.41% Sonendo -92.74% -184.01% -68.60%

Do analysts recommend ICCM or SONX?

IceCure Medical presently has a consensus target price of $62.70, suggesting a potential upside of 1,935.71%. Given IceCure Medical's stronger consensus rating and higher probable upside, research analysts clearly believe IceCure Medical is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IceCure Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is ICCM or SONX more profitable?

Sonendo has a net margin of -92.74% compared to IceCure Medical's net margin of -441.60%. Sonendo's return on equity of -184.01% beat IceCure Medical's return on equity. Company Net Margins Return on Equity Return on Assets IceCure Medical -441.60% -211.73% -119.13% Sonendo -92.74% -184.01% -68.60%

Do analysts rate FEMY or SONX?

Femasys presently has a consensus target price of $106.67, indicating a potential upside of 2,775.11%. Given Femasys' stronger consensus rating and higher probable upside, analysts clearly believe Femasys is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings and valuation, FEMY or SONX?

Femasys has higher earnings, but lower revenue than Sonendo. Femasys is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Femasys $2.38M 4.71 -$18.63M -$5.40 N/A Sonendo $44.40M 0.11 -$60.92M -$71.12 N/A

Is FEMY or SONX more profitable?

Sonendo has a net margin of -92.74% compared to Femasys' net margin of -521.97%. Sonendo's return on equity of -184.01% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Femasys -521.97% -258.08% -73.72% Sonendo -92.74% -184.01% -68.60%

Do analysts rate SONX or NXL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SONX or NXL more profitable?

Sonendo has a net margin of -92.74% compared to Nexalin Technology's net margin of -3,018.12%. Sonendo's return on equity of -184.01% beat Nexalin Technology's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Nexalin Technology -3,018.12% -191.88% -166.43%

Sonendo (SONX) Competitors

$1.01 0.00 (0.00%)

As of 07/24/2026

Compare

SONX vs. ZJYL, OSRH, ICCM, FEMY, and NXL

Should you buy Sonendo stock or one of its competitors? MarketBeat compares Sonendo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sonendo include Jin Medical International (ZJYL), OSR (OSRH), IceCure Medical (ICCM), Femasys (FEMY), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry.

How does Sonendo compare to Jin Medical International?

Sonendo (NYSE:SONX) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Jin Medical International has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Jin Medical International's return on equity of 0.00% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Jin Medical International	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

28.7% of Sonendo shares are held by institutional investors. 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Sonendo has a beta of 1.86, suggesting that its stock price is 86% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.34, suggesting that its stock price is 634% more volatile than the broader market.

Jin Medical International has lower revenue, but higher earnings than Sonendo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.11	-$60.92M	-$71.12	N/A
Jin Medical International	$20.69M	0.65	$1.19M	N/A	N/A

In the previous week, Jin Medical International had 4 more articles in the media than Sonendo. MarketBeat recorded 4 mentions for Jin Medical International and 0 mentions for Sonendo. Jin Medical International's average media sentiment score of 0.50 beat Sonendo's score of 0.00 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Overall Sentiment
Sonendo	Neutral
Jin Medical International	Positive

Summary

Jin Medical International beats Sonendo on 9 of the 12 factors compared between the two stocks.

How does Sonendo compare to OSR?

OSR (NASDAQ:OSRH) and Sonendo (NYSE:SONX) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

OSR has higher earnings, but lower revenue than Sonendo. OSR is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.63M	5.65	-$27.06M	-$0.33	N/A
Sonendo	$44.40M	0.11	-$60.92M	-$71.12	N/A

Sonendo has a net margin of -92.74% compared to OSR's net margin of -363.26%. OSR's return on equity of -7.24% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Sonendo	-92.74%	-184.01%	-68.60%

OSR has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.86, suggesting that its stock price is 86% more volatile than the broader market.

55.3% of OSR shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 36.9% of OSR shares are held by company insiders. Comparatively, 7.9% of Sonendo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, OSR had 2 more articles in the media than Sonendo. MarketBeat recorded 2 mentions for OSR and 0 mentions for Sonendo. OSR's average media sentiment score of 1.31 beat Sonendo's score of 0.00 indicating that OSR is being referred to more favorably in the media.

Company	Overall Sentiment
OSR	Positive
Sonendo	Neutral

Summary

OSR beats Sonendo on 10 of the 14 factors compared between the two stocks.

How does Sonendo compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability.

IceCure Medical has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market.

IceCure Medical has higher earnings, but lower revenue than Sonendo. IceCure Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.57M	2.96	-$15.06M	-$7.21	N/A
Sonendo	$44.40M	0.11	-$60.92M	-$71.12	N/A

In the previous week, IceCure Medical had 3 more articles in the media than Sonendo. MarketBeat recorded 3 mentions for IceCure Medical and 0 mentions for Sonendo. IceCure Medical's average media sentiment score of 0.96 beat Sonendo's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company	Overall Sentiment
IceCure Medical	Positive
Sonendo	Neutral

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Sonendo has a net margin of -92.74% compared to IceCure Medical's net margin of -441.60%. Sonendo's return on equity of -184.01% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-441.60%	-211.73%	-119.13%
Sonendo	-92.74%	-184.01%	-68.60%

IceCure Medical presently has a consensus target price of $62.70, suggesting a potential upside of 1,935.71%. Given IceCure Medical's stronger consensus rating and higher probable upside, research analysts clearly believe IceCure Medical is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

IceCure Medical and Sonendo tied by winning 8 of the 16 factors compared between the two stocks.

How does Sonendo compare to Femasys?

Femasys (NASDAQ:FEMY) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Femasys has a beta of -2.13, suggesting that its share price is 313% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.86, suggesting that its share price is 86% more volatile than the broader market.

Sonendo has a net margin of -92.74% compared to Femasys' net margin of -521.97%. Sonendo's return on equity of -184.01% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-521.97%	-258.08%	-73.72%
Sonendo	-92.74%	-184.01%	-68.60%

Femasys has higher earnings, but lower revenue than Sonendo. Femasys is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.38M	4.71	-$18.63M	-$5.40	N/A
Sonendo	$44.40M	0.11	-$60.92M	-$71.12	N/A

Femasys presently has a consensus target price of $106.67, indicating a potential upside of 2,775.11%. Given Femasys' stronger consensus rating and higher probable upside, analysts clearly believe Femasys is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

65.3% of Femasys shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 7.8% of Femasys shares are held by insiders. Comparatively, 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Femasys had 2 more articles in the media than Sonendo. MarketBeat recorded 2 mentions for Femasys and 0 mentions for Sonendo. Femasys' average media sentiment score of 0.94 beat Sonendo's score of 0.00 indicating that Femasys is being referred to more favorably in the media.

Company	Overall Sentiment
Femasys	Positive
Sonendo	Neutral

Summary

Femasys beats Sonendo on 9 of the 16 factors compared between the two stocks.

How does Sonendo compare to Nexalin Technology?

Sonendo (NYSE:SONX) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

28.7% of Sonendo shares are held by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are held by institutional investors. 7.9% of Sonendo shares are held by company insiders. Comparatively, 16.9% of Nexalin Technology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sonendo has a net margin of -92.74% compared to Nexalin Technology's net margin of -3,018.12%. Sonendo's return on equity of -184.01% beat Nexalin Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Nexalin Technology	-3,018.12%	-191.88%	-166.43%

Sonendo has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market. Comparatively, Nexalin Technology has a beta of 4, indicating that its share price is 300% more volatile than the broader market.

In the previous week, Nexalin Technology had 2 more articles in the media than Sonendo. MarketBeat recorded 2 mentions for Nexalin Technology and 0 mentions for Sonendo. Nexalin Technology's average media sentiment score of 0.93 beat Sonendo's score of 0.00 indicating that Nexalin Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Sonendo	Neutral
Nexalin Technology	Positive

Nexalin Technology has lower revenue, but higher earnings than Sonendo. Nexalin Technology is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.11	-$60.92M	-$71.12	N/A
Nexalin Technology	$275.58K	38.43	-$8.22M	-$0.47	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Nexalin Technology beats Sonendo on 8 of the 14 factors compared between the two stocks.

Get Sonendo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SONX vs. The Competition

Export

Metric	Sonendo	Dental equipment & supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$4.82M	$4.82M	$6.87B	$23.47B
Dividend Yield	N/A	N/A	2.67%	4.20%
P/E Ratio	-0.01	N/A	27.14	30.75
Price / Sales	0.11	0.11	517.06	166.31
Price / Cash	N/A	N/A	50.54	31.69
Price / Book	0.01	0.01	10.28	4.73
Net Income	-$60.92M	-$60.92M	$3.60B	$1.07B
7 Day Performance	23.17%	23.17%	-1.27%	-0.45%
1 Month Performance	N/A	68.33%	-0.37%	0.72%
1 Year Performance	-12.17%	-12.17%	18.30%	14.09%

Sonendo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SONX Sonendo	N/A	$1.01 flat	N/A	-12.2%	$4.82M	$44.40M	N/A	250
ZJYL Jin Medical International	0.6109 of 5 stars	$1.90 -2.1%	N/A	-85.1%	$15.19M	$20.69M	N/A	245	Short Interest Increase
OSRH OSR	0.9744 of 5 stars	$0.49 +15.5%	N/A	-56.0%	$14.76M	$2.91M	N/A	N/A	High Trading Volume
ICCM IceCure Medical	3.6651 of 5 stars	$3.66 +1.7%	$62.70 +1,613.1%	-89.6%	$12.34M	$3.38M	N/A	60	Short Interest Decrease
FEMY Femasys	1.6963 of 5 stars	$3.05 -14.6%	$106.67 +3,397.3%	-79.7%	$10.78M	$2.29M	N/A	30

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SONX) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sonendo (SONX) Competitors

SONX vs. ZJYL, OSRH, ICCM, FEMY, and NXL

How does Sonendo compare to Jin Medical International?

Summary

How does Sonendo compare to OSR?

Summary

How does Sonendo compare to IceCure Medical?

Summary

How does Sonendo compare to Femasys?

Summary

How does Sonendo compare to Nexalin Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sonendo (SONX) Competitors

SONX vs. ZJYL, OSRH, ICCM, FEMY, and NXL

How does Sonendo compare to Jin Medical International?

Is SONX or ZJYL more profitable?

Do analysts prefer SONX or ZJYL?

Do insiders and institutionals have more ownership in SONX or ZJYL?

Which has more risk and volatility, SONX or ZJYL?

Which has better valuation & earnings, SONX or ZJYL?

Does the media prefer SONX or ZJYL?

Summary

How does Sonendo compare to OSR?

Which has stronger earnings & valuation, OSRH or SONX?

Is OSRH or SONX more profitable?

Which has more volatility and risk, OSRH or SONX?

Do institutionals & insiders have more ownership in OSRH or SONX?

Do analysts prefer OSRH or SONX?

Does the media favor OSRH or SONX?

Summary

How does Sonendo compare to IceCure Medical?

Which has more volatility & risk, ICCM or SONX?

Which has better valuation & earnings, ICCM or SONX?

Does the media refer more to ICCM or SONX?

Do insiders & institutionals believe in ICCM or SONX?

Is ICCM or SONX more profitable?

Do analysts recommend ICCM or SONX?

Summary

How does Sonendo compare to Femasys?

Which has more volatility & risk, FEMY or SONX?

Is FEMY or SONX more profitable?

Which has higher earnings and valuation, FEMY or SONX?

Do analysts rate FEMY or SONX?

Do insiders and institutionals have more ownership in FEMY or SONX?

Does the media favor FEMY or SONX?

Summary

How does Sonendo compare to Nexalin Technology?

Do institutionals and insiders hold more shares of SONX or NXL?

Is SONX or NXL more profitable?

Which has more risk & volatility, SONX or NXL?

Does the media prefer SONX or NXL?

Which has higher valuation & earnings, SONX or NXL?

Do analysts rate SONX or NXL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools